baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Wave Life Sciences Ltd/ SG9999014716 /

2024-08-01 3:44:04 PM	Chg. -0.0900	Volume	Bid3:45:09 PM	Ask3:45:09 PM	High	Low
6.5200USD	-1.36%	26,154 Turnover: 158,745.9300	6.5000Bid Size: 400	6.5500Ask Size: 200	6.5650	6.4450

GlobeNewswire 06-25 Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical D...

GlobeNewswire 06-12 Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and ...

GlobeNewswire 05-30 Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference

GlobeNewswire 05-09 Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 05-09 Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer

GlobeNewswire 05-07 Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference

GlobeNewswire 05-02 Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024

GlobeNewswire 04-30 Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial o...

GlobeNewswire 04-23 Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and R...

GlobeNewswire 03-27 Wave Life Sciences to Present at Upcoming Investor Conferences

GlobeNewswire 03-06 Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business...

GlobeNewswire 02-28 Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024

GlobeNewswire 02-27 Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class P...

GlobeNewswire 01-08 Wave Life Sciences Highlights Recent Achievements and Upcoming 2024 Milestones

GlobeNewswire 01-03 US Neurologists Optimistic Regarding the Huntington’s Disease Treatment Pipeline, Emphasizing Haltin...

GlobeNewswire 01-03 Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire 2023-12-15 Wave Life Sciences Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531 in Duchenn...

GlobeNewswire 2023-12-07 Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares

GlobeNewswire 2023-12-06 Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants

GlobeNewswire 2023-12-06 Wave Life Sciences Announces Initiation of Dosing in RestorAATion Clinical Program Evaluating First-...

GlobeNewswire 2023-11-28 Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics...

GlobeNewswire 2023-11-22 Wave Life Sciences to Present at 6ᵗʰ Annual Evercore ISI HealthCONx Conference

GlobeNewswire 2023-11-09 Wave Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire 2023-11-03 Wave Life Sciences Third Quarter 2023 Financial Results Scheduled for November 9, 2023

GlobeNewswire 2023-09-28 Wave Life Sciences Highlights Growth Strategy for Building the Leading RNA Medicines Company in Annu...

Wave Life Sciences Ltd/ SG9999014716 /

If you wish to receive reply to your feedback, please provide your email address.